1990
DOI: 10.1128/jcm.28.8.1766-1769.1990
|View full text |Cite
|
Sign up to set email alerts
|

Preparation of species-specific murine monoclonal antibodies against the yeast phase of Paracoccidioides brasiliensis

Abstract: A panel of four murine monoclonal antibodies showing species specificity for the yeast phase of the pathogenic dimorphic fungus Paracoccidioides brasiliensis was produced by using a modification of the standard monoclonal antibody technology. This involved the use of the immunosuppressive drug cyclophosphamide to suppress the immune response of test animals to fungi showing cross-reactivity, i.e., to Histoplasma capsulatum. One monoclonal antibody, P4, which had a high titer by enzyme-linked immunosorbent assa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
19
0

Year Published

1990
1990
2016
2016

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 19 publications
(19 citation statements)
references
References 24 publications
0
19
0
Order By: Relevance
“…Fungal isolates and antigen preparations. The following pathogenic fungi were cultured and harvested as previously described ( (4,11).…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations
“…Fungal isolates and antigen preparations. The following pathogenic fungi were cultured and harvested as previously described ( (4,11).…”
Section: Methodsmentioning
confidence: 99%
“…MAb production. The modification by Hamilton et al (4,11) of the Matthew and Sandrock protocol (14) was used. Briefly, 10 BALB/c mice were inoculated intraperitoneally (i.p.)…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Puccia and Travassos produced antibodies against the 43-kDa glycoprotein to foster their experimental studies on its excretion and proteolysis (236). Figueroa et al prepared monoclonal antibodies to define species-specific epitopes, and they discussed the potential use of monoclonal antibodies in serodiagnosis and the development of an ELISA for the detection of circulating antigen (107).…”
Section: Immunodiagnosismentioning
confidence: 99%